A case of large-cell lung carcinoma successfully treated with pembrolizumab but complicated with cholangitis

Large-cell carcinoma (LCC) of the lung is defined as an undifferentiated non-small cell lung cancer (NSCLC) and accounts for approximately 7.5% of lung cancers. Immune checkpoint inhibitors (ICIs) may be effective for LCC, but there has been no firm evidence due to its low frequency. We herein repor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Respir Med Case Rep
Glavni autori: Ooi, Ryunosuke, Tobino, Kazunori, Sakabe, Mitsukuni, Kawabata, Takafumi, Hiramatsu, Yuri, Sueyasu, Takuto, Yoshimine, Kohei
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481563/
https://ncbi.nlm.nih.gov/pubmed/32944497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101197
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items